Durham, NC, United States of America

Greg Palmer

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Duke University. Active years: 2022.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Greg Palmer

Introduction

Greg Palmer is an accomplished inventor based in Durham, NC (US), known for his significant contributions to cancer treatment methodologies. With a focus on synergistic nanotherapy systems, Palmer's work aims to enhance the effectiveness of cancer therapies.

Latest Patents

Palmer holds a patent for "Synergistic nanotherapy systems and methods of use thereof." This innovative method is designed to treat various forms of cancer, including metastatic bladder and breast cancer. The approach involves administering a plasmonics-active metal nanoparticle to target primary cancer cells while simultaneously exposing the subject to photon radiation. Additionally, the method incorporates an immune checkpoint modulator, creating a synergistic effect that offers a rapid, safe, and effective treatment for both local and distant lesions.

Career Highlights

Palmer's career is marked by his dedication to advancing cancer treatment through innovative research. His work at Duke University has positioned him as a leader in the field of nanotherapy, where he continues to explore new avenues for improving patient outcomes.

Collaborations

Palmer collaborates with esteemed colleagues, including Tuan Vo-Dinh and Brant A Inman, who contribute to the research and development of his innovative cancer treatment methods.

Conclusion

Greg Palmer's pioneering work in synergistic nanotherapy systems represents a significant advancement in cancer treatment. His innovative approach has the potential to transform how cancer is treated, offering hope to patients facing challenging diagnoses.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…